ID
31488
Beskrivning
Study ID: 104619 Clinical Study ID: 63129 Study Title:A multinational, randomized, double-blind comparison of once daily subcutaneous fondaparinux sodium with placebo for the prevention of venous thromboembolic events in acutely ill medical patients (ARTEMIS). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fondaparinux sodium Trade Name: Arixtra Study Indication: Thrombosis, Venous
Nyckelord
Versioner (1)
- 2018-08-28 2018-08-28 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
28 augusti 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Subcutaneous fondaparinux sodium for prevention of venous thromboembolic events; Study ID: 104619
End of Treatment/End of Study
- StudyEvent: ODM
Beskrivning
End of Study
Alias
- UMLS CUI-1
- C0008972
- UMLS CUI-2
- C0444930
Beskrivning
Study end Date
Datatyp
date
Alias
- UMLS CUI [1]
- C2983670
Beskrivning
Clinical Research, end; Reason
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0008972
- UMLS CUI [1,2]
- C0444930
- UMLS CUI [1,3]
- C0566251
Beskrivning
Clinical Research; study code
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0008972
- UMLS CUI [1,2]
- C0805701
Similar models
End of Treatment/End of Study
- StudyEvent: ODM
C1762893 (UMLS CUI [1,2])
C0444930 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
C0444930 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
C0805701 (UMLS CUI [1,2])